| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | zf-C2H2_6 | ZNF502 ZNF845 ZNF670 ZNF14 ZNF20 ZNF197 ZNF799 ZNF761 ZNF30 ZNF543 ZNF700 ZNF564 ZFP2 ZNF443 ZNF433 | 1.32e-09 | 314 | 118 | 15 | PF13912 |
| Domain | KRAB | ZNF845 ZNF670 ZNF563 ZNF14 ZNF20 ZNF197 ZNF799 ZNF470 ZNF761 ZNF30 ZNF543 ZNF700 ZNF564 ZNF443 ZNF433 | 7.83e-09 | 358 | 118 | 15 | PS50805 |
| Domain | KRAB | ZNF845 ZNF670 ZNF563 ZNF14 ZNF20 ZNF197 ZNF799 ZNF470 ZNF761 ZNF30 ZNF543 ZNF700 ZNF564 ZNF443 ZNF433 | 7.83e-09 | 358 | 118 | 15 | PF01352 |
| Domain | KRAB | ZNF845 ZNF670 ZNF563 ZNF14 ZNF20 ZNF197 ZNF799 ZNF470 ZNF761 ZNF30 ZNF543 ZNF700 ZNF564 ZNF443 ZNF433 | 1.17e-08 | 369 | 118 | 15 | SM00349 |
| Domain | KRAB | ZNF845 ZNF670 ZNF563 ZNF14 ZNF20 ZNF197 ZNF799 ZNF470 ZNF761 ZNF30 ZNF543 ZNF700 ZNF564 ZNF443 ZNF433 | 1.22e-08 | 370 | 118 | 15 | IPR001909 |
| Domain | - | ZNF502 ZNF845 ZNF670 ZNF563 HINFP ZNF14 ZNF20 ZNF197 ZNF799 ZNF470 ZNF761 ZNF30 ZNF543 ZNF700 ZNF564 ZFP2 ZNF443 ZNF433 | 2.58e-07 | 679 | 118 | 18 | 3.30.160.60 |
| Domain | zf-C2H2 | ZNF502 ZNF845 ZNF670 ZNF563 HINFP ZNF14 ZNF20 ZNF197 ZNF799 ZNF470 ZNF761 ZNF30 ZNF543 ZNF700 ZNF564 ZFP2 ZNF443 ZNF433 | 3.47e-07 | 693 | 118 | 18 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF502 ZNF845 ZNF670 ZNF563 HINFP ZNF14 ZNF20 ZNF197 ZNF799 ZNF470 ZNF761 ZNF30 ZNF543 ZNF700 ZNF564 ZFP2 ZNF443 ZNF433 | 3.55e-07 | 694 | 118 | 18 | IPR013087 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF502 ZNF845 ZNF670 ZNF563 HINFP ZNF14 ZNF20 ZNF197 ZNF799 ZNF470 ZNF761 ZNF30 ZNF543 ZNF700 ZNF564 ZFP2 ZNF443 ZNF433 | 1.74e-06 | 775 | 118 | 18 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF502 ZNF845 ZNF670 ZNF563 HINFP ZNF14 ZNF20 ZNF197 ZNF799 ZNF470 ZNF761 ZNF30 ZNF543 ZNF700 ZNF564 ZFP2 ZNF443 ZNF433 | 1.80e-06 | 777 | 118 | 18 | PS00028 |
| Domain | Znf_C2H2-like | ZNF502 ZNF845 ZNF670 ZNF563 HINFP ZNF14 ZNF20 ZNF197 ZNF799 ZNF470 ZNF761 ZNF30 ZNF543 ZNF700 ZNF564 ZFP2 ZNF443 ZNF433 | 2.53e-06 | 796 | 118 | 18 | IPR015880 |
| Domain | Znf_C2H2 | ZNF502 ZNF845 ZNF670 ZNF563 HINFP ZNF14 ZNF20 ZNF197 ZNF799 ZNF470 ZNF761 ZNF30 ZNF543 ZNF700 ZNF564 ZFP2 ZNF443 ZNF433 | 2.96e-06 | 805 | 118 | 18 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF502 ZNF845 ZNF670 ZNF563 HINFP ZNF14 ZNF20 ZNF197 ZNF799 ZNF470 ZNF761 ZNF30 ZNF543 ZNF700 ZNF564 ZFP2 ZNF443 ZNF433 | 3.12e-06 | 808 | 118 | 18 | SM00355 |
| Domain | Integrin_alpha_C_CS | 1.30e-04 | 16 | 118 | 3 | IPR018184 | |
| Domain | Integrin_alpha-2 | 1.87e-04 | 18 | 118 | 3 | IPR013649 | |
| Domain | INTEGRIN_ALPHA | 1.87e-04 | 18 | 118 | 3 | PS00242 | |
| Domain | Integrin_alpha2 | 1.87e-04 | 18 | 118 | 3 | PF08441 | |
| Domain | Integrin_alpha | 1.87e-04 | 18 | 118 | 3 | IPR000413 | |
| Domain | Int_alpha | 2.21e-04 | 19 | 118 | 3 | SM00191 | |
| Domain | Int_alpha_beta-p | 2.21e-04 | 19 | 118 | 3 | IPR013519 | |
| Domain | FG_GAP | 3.47e-04 | 22 | 118 | 3 | PS51470 | |
| Domain | Anaphylatoxin_comp_syst | 3.91e-04 | 5 | 118 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 3.91e-04 | 5 | 118 | 2 | IPR001840 | |
| Domain | FG-GAP | 4.52e-04 | 24 | 118 | 3 | PF01839 | |
| Domain | FG-GAP | 4.52e-04 | 24 | 118 | 3 | IPR013517 | |
| Domain | Integrin_dom | 5.11e-04 | 25 | 118 | 3 | IPR032695 | |
| Domain | Lipase_euk | 5.84e-04 | 6 | 118 | 2 | IPR025483 | |
| Domain | Abhydro_lipase | 5.84e-04 | 6 | 118 | 2 | PF04083 | |
| Domain | AB_hydrolase_lipase | 5.84e-04 | 6 | 118 | 2 | IPR006693 | |
| Domain | ANATO | 8.14e-04 | 7 | 118 | 2 | SM00104 | |
| Domain | STAT_TF_DNA-bd_sub | 8.14e-04 | 7 | 118 | 2 | IPR012345 | |
| Domain | STAT | 8.14e-04 | 7 | 118 | 2 | IPR001217 | |
| Domain | CAMSAP_CH | 8.14e-04 | 7 | 118 | 2 | PF11971 | |
| Domain | STAT_int | 8.14e-04 | 7 | 118 | 2 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 8.14e-04 | 7 | 118 | 2 | IPR013801 | |
| Domain | STAT_bind | 8.14e-04 | 7 | 118 | 2 | PF02864 | |
| Domain | STAT_int | 8.14e-04 | 7 | 118 | 2 | PF02865 | |
| Domain | ANAPHYLATOXIN_2 | 8.14e-04 | 7 | 118 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 8.14e-04 | 7 | 118 | 2 | PS01177 | |
| Domain | - | 8.14e-04 | 7 | 118 | 2 | 1.10.532.10 | |
| Domain | STAT_alpha | 8.14e-04 | 7 | 118 | 2 | PF01017 | |
| Domain | - | 8.14e-04 | 7 | 118 | 2 | 1.20.1050.20 | |
| Domain | STAT_TF_prot_interaction | 8.14e-04 | 7 | 118 | 2 | IPR013799 | |
| Domain | STAT_TF_coiled-coil | 8.14e-04 | 7 | 118 | 2 | IPR015988 | |
| Domain | - | 8.14e-04 | 7 | 118 | 2 | 2.60.40.630 | |
| Domain | ANATO | 8.14e-04 | 7 | 118 | 2 | PF01821 | |
| Domain | CAMSAP_CH | 8.14e-04 | 7 | 118 | 2 | IPR022613 | |
| Domain | Anaphylatoxin/fibulin | 8.14e-04 | 7 | 118 | 2 | IPR000020 | |
| Domain | Abhydrolase_1 | 9.71e-04 | 31 | 118 | 3 | PF00561 | |
| Domain | STAT_TF_alpha | 1.08e-03 | 8 | 118 | 2 | IPR013800 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 1.08e-03 | 8 | 118 | 2 | IPR019565 | |
| Domain | Thiol-ester_cl | 1.08e-03 | 8 | 118 | 2 | PF10569 | |
| Domain | MacrogloblnA2_CS | 1.08e-03 | 8 | 118 | 2 | IPR019742 | |
| Domain | AB_hydrolase_1 | 1.17e-03 | 33 | 118 | 3 | IPR000073 | |
| Domain | A2M | 1.72e-03 | 10 | 118 | 2 | PF00207 | |
| Domain | A2M_N_2 | 1.72e-03 | 10 | 118 | 2 | IPR011625 | |
| Domain | A2M_comp | 1.72e-03 | 10 | 118 | 2 | IPR011626 | |
| Domain | A2M_recep | 1.72e-03 | 10 | 118 | 2 | PF07677 | |
| Domain | A2M_comp | 1.72e-03 | 10 | 118 | 2 | PF07678 | |
| Domain | A2M_N | 1.72e-03 | 10 | 118 | 2 | PF01835 | |
| Domain | A2M_N | 1.72e-03 | 10 | 118 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.72e-03 | 10 | 118 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.72e-03 | 10 | 118 | 2 | PS00477 | |
| Domain | A2M_N_2 | 1.72e-03 | 10 | 118 | 2 | PF07703 | |
| Domain | Macroglobln_a2 | 1.72e-03 | 10 | 118 | 2 | IPR001599 | |
| Domain | Integrin_alpha | 2.10e-03 | 11 | 118 | 2 | PF00357 | |
| Domain | C345C | 5.06e-03 | 17 | 118 | 2 | SM00643 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 5.67e-03 | 18 | 118 | 2 | IPR008930 | |
| Domain | NTR | 6.31e-03 | 19 | 118 | 2 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 6.31e-03 | 19 | 118 | 2 | IPR018933 | |
| Domain | Pyr_redox_2 | 6.31e-03 | 19 | 118 | 2 | PF07992 | |
| Pathway | REACTOME_SIGNALING_BY_LEPTIN | 3.03e-05 | 11 | 82 | 3 | M27195 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HORMONE_LIKE_CYTOKINE_TO_JAK_STAT_SIGNALING_PATHWAY | 1.22e-04 | 17 | 82 | 3 | M47905 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.57e-04 | 47 | 82 | 4 | MM14925 | |
| Pathway | REACTOME_SIGNAL_TRANSDUCTION_BY_L1 | 1.72e-04 | 19 | 82 | 3 | MM15113 | |
| Pathway | PID_PTP1B_PATHWAY | 2.33e-04 | 52 | 82 | 4 | M50 | |
| Pathway | REACTOME_SIGNAL_TRANSDUCTION_BY_L1 | 2.34e-04 | 21 | 82 | 3 | M878 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ZNF670 ITGA2B ZNF563 ZNF14 ZNF20 ZNF197 SERPINE1 ZNF799 ZNF470 ZNF761 ZNF30 ZNF543 ZNF700 ZNF564 ZFP2 ZNF443 ZNF433 MOV10 DYRK2 | 3.04e-04 | 1387 | 82 | 19 | M734 |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY | 3.09e-04 | 23 | 82 | 3 | M47537 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 3.09e-04 | 23 | 82 | 3 | M47720 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY | 3.30e-04 | 5 | 82 | 2 | M48987 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_JAK_STAT_SIGNALING_PATHWAY | 3.30e-04 | 5 | 82 | 2 | M48986 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY | 3.30e-04 | 5 | 82 | 2 | M49006 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 4.48e-04 | 26 | 82 | 3 | M47 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_CDC42_SIGNALING_PATHWAY | 4.48e-04 | 26 | 82 | 3 | M47719 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 4.94e-04 | 6 | 82 | 2 | MM15581 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 4.94e-04 | 6 | 82 | 2 | MM15621 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY | 5.60e-04 | 28 | 82 | 3 | M47655 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 6.88e-04 | 30 | 82 | 3 | M47724 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY | 6.88e-04 | 30 | 82 | 3 | M47718 | |
| Pathway | REACTOME_STAT5_ACTIVATION | 6.89e-04 | 7 | 82 | 2 | M27953 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY | 6.89e-04 | 7 | 82 | 2 | M47581 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY | 6.89e-04 | 7 | 82 | 2 | M47646 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 6.89e-04 | 7 | 82 | 2 | MM14685 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY | 6.89e-04 | 7 | 82 | 2 | M47430 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5 | 6.89e-04 | 7 | 82 | 2 | M27907 | |
| Pathway | REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION | 7.58e-04 | 31 | 82 | 3 | M661 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 9.15e-04 | 8 | 82 | 2 | M47872 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 9.15e-04 | 8 | 82 | 2 | M27031 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 9.93e-04 | 76 | 82 | 4 | MM14867 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 9.93e-04 | 76 | 82 | 4 | M27219 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 1.17e-03 | 9 | 82 | 2 | M27861 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 1.17e-03 | 9 | 82 | 2 | MM1419 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 1.17e-03 | 9 | 82 | 2 | M8066 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE | 1.38e-03 | 38 | 82 | 3 | M27536 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 1.46e-03 | 10 | 82 | 2 | M27898 | |
| Pathway | REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS | 1.46e-03 | 10 | 82 | 2 | M41731 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 1.46e-03 | 10 | 82 | 2 | MM15618 | |
| Pathway | KEGG_REGULATION_OF_ACTIN_CYTOSKELETON | 1.50e-03 | 213 | 82 | 6 | M18306 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.51e-03 | 85 | 82 | 4 | M16441 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 1.78e-03 | 11 | 82 | 2 | M47874 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 1.78e-03 | 11 | 82 | 2 | MM15578 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 1.78e-03 | 11 | 82 | 2 | MM1430 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 2.12e-03 | 12 | 82 | 2 | MM1368 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 2.12e-03 | 12 | 82 | 2 | M27893 | |
| Pubmed | ZNF845 ZNF670 ZNF563 ZNF20 ZNF197 MKLN1 ZNF799 ZNF543 ZNF564 | 1.36e-08 | 181 | 119 | 9 | 37372979 | |
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 23696567 | ||
| Pubmed | Growth hormone enhances the recovery of hypoglycemia via ventromedial hypothalamic neurons. | 3.89e-07 | 5 | 119 | 3 | 31366244 | |
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 17726024 | ||
| Pubmed | Transcriptional and physiological roles for STAT proteins in leptin action. | 1.35e-06 | 7 | 119 | 3 | 30718218 | |
| Pubmed | Integrin-Alpha IIb Identifies Murine Lymph Node Lymphatic Endothelial Cells Responsive to RANKL. | 2.16e-06 | 8 | 119 | 3 | 27010197 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 1.16e-05 | 2 | 119 | 2 | 16565498 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 15998580 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 23151802 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 26999798 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 19062096 | ||
| Pubmed | A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions. | 1.16e-05 | 2 | 119 | 2 | 31443474 | |
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 1.16e-05 | 2 | 119 | 2 | 19933335 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 12377952 | ||
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 1.16e-05 | 2 | 119 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 1.16e-05 | 2 | 119 | 2 | 17645767 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 12207352 | ||
| Pubmed | A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. | 1.16e-05 | 2 | 119 | 2 | 21127177 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 16289657 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 1.16e-05 | 2 | 119 | 2 | 27758680 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 25552366 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 22387014 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 25470773 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 1.16e-05 | 2 | 119 | 2 | 23749435 | |
| Pubmed | Constitutively active Stat5A and Stat5B promote adipogenesis. | 1.16e-05 | 2 | 119 | 2 | 21431790 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 23918728 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 28500076 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 21826656 | ||
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 1.16e-05 | 2 | 119 | 2 | 3037333 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 11726230 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 4216347 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 7720707 | ||
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 1.16e-05 | 2 | 119 | 2 | 6950384 | |
| Pubmed | STAT5A and STAT5B have opposite correlations with drug response gene expression. | 1.16e-05 | 2 | 119 | 2 | 27264955 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 20660625 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 8660986 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 1.16e-05 | 2 | 119 | 2 | 8428773 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 22159083 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 24638111 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 20008792 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 1.16e-05 | 2 | 119 | 2 | 21345967 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 33199496 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 2572548 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 2302180 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 32513532 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 16502315 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 1.16e-05 | 2 | 119 | 2 | 18091514 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 29080553 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 12217382 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 1.16e-05 | 2 | 119 | 2 | 25339671 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 31599926 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 17728371 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 10594041 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 21036145 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 10486277 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 6149580 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 6149581 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 12115608 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 3542363 | ||
| Pubmed | Identification of human STAT5-dependent gene regulatory elements based on interspecies homology. | 1.16e-05 | 2 | 119 | 2 | 16840779 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 2387317 | ||
| Pubmed | The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells. | 1.16e-05 | 2 | 119 | 2 | 15128421 | |
| Pubmed | STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice. | 1.16e-05 | 2 | 119 | 2 | 30377054 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 23565285 | ||
| Pubmed | Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer. | 1.16e-05 | 2 | 119 | 2 | 32790723 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 18492722 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 10066807 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 10835485 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 35464049 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 16908004 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 7365238 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 18286195 | ||
| Pubmed | Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells. | 1.16e-05 | 2 | 119 | 2 | 23773921 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 8631883 | ||
| Pubmed | Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. | 1.16e-05 | 2 | 119 | 2 | 11030348 | |
| Pubmed | Association between STAT5 polymorphisms and glioblastoma risk in Han Chinese population. | 1.16e-05 | 2 | 119 | 2 | 24878107 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 7391573 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 17971360 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 38203500 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 12847485 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 12835478 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 7568026 | ||
| Pubmed | Identification of STAT5A and STAT5B target genes in human T cells. | 1.16e-05 | 2 | 119 | 2 | 24497979 | |
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 1.16e-05 | 2 | 119 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 1.16e-05 | 2 | 119 | 2 | 17971229 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 17536022 | ||
| Pubmed | STAT5 transcriptional activity is impaired by LIF in a mammary epithelial cell line. | 1.16e-05 | 2 | 119 | 2 | 17382296 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 6881182 | ||
| Pubmed | STAT5 is essential for Akt/p70S6 kinase activity during IL-2-induced lymphocyte proliferation. | 1.16e-05 | 2 | 119 | 2 | 17911616 | |
| Pubmed | STAT5 signaling in sexually dimorphic gene expression and growth patterns. | 1.16e-05 | 2 | 119 | 2 | 10486314 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 17599554 | ||
| Pubmed | MiR-21 is under control of STAT5 but is dispensable for mammary development and lactation. | 1.16e-05 | 2 | 119 | 2 | 24497923 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 23761674 | ||
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 1.16e-05 | 2 | 119 | 2 | 17921792 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 21880985 | ||
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 1.16e-05 | 2 | 119 | 2 | 6978711 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 35898513 | ||
| Cytoband | 19p13.2 | 1.65e-07 | 229 | 119 | 8 | 19p13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | UBXN6 ZNF563 ZNF14 ZNF20 MAST1 ZNF799 DOT1L ZNF700 ZNF564 ZNF443 ZNF433 | 7.77e-06 | 797 | 119 | 11 | chr19p13 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q26 | 7.81e-04 | 16 | 119 | 2 | chr6q26 | |
| Cytoband | 6q26 | 9.92e-04 | 18 | 119 | 2 | 6q26 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | ZNF845 BICRA CADM4 FCGBP TSEN34 ZNF470 ZNF761 ZNF30 ZNF543 NLRP8 | 1.11e-03 | 1192 | 119 | 10 | chr19q13 |
| Cytoband | 19q13.43 | 1.54e-03 | 87 | 119 | 3 | 19q13.43 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF502 ZNF845 ZNF670 ZNF563 HINFP ZNF14 ZNF20 ZNF197 ZNF799 ZNF470 ZNF761 ZNF30 ZNF543 ZNF700 ZNF564 ZFP2 ZNF443 ZNF433 | 1.05e-08 | 718 | 89 | 18 | 28 |
| GeneFamily | CD molecules|Integrin alpha subunits | 8.92e-05 | 18 | 89 | 3 | 1160 | |
| GeneFamily | Complement system|Sushi domain containing | 7.32e-04 | 36 | 89 | 3 | 492 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 8.43e-04 | 9 | 89 | 2 | 1234 | |
| Coexpression | GAO_ESOPHAGUS_25W_C4_FGFR1HIGH_EPITHELIAL_CELLS | 4.76e-06 | 208 | 118 | 8 | M39139 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.78e-08 | 191 | 119 | 8 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.78e-08 | 191 | 119 | 8 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.59e-07 | 195 | 119 | 7 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.59e-07 | 195 | 119 | 7 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.92e-07 | 196 | 119 | 7 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.92e-07 | 196 | 119 | 7 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | 1.06e-06 | 198 | 119 | 7 | ca26ca460856b1faaa3e83766da6abdf63af2b51 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-06 | 138 | 119 | 6 | c1a46fbf1beffa12c3d1b78361e0613e2e9e2d13 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.49e-06 | 170 | 119 | 6 | fa753cc8fbd04e63c9a303da4dc17ee2ce907f92 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.49e-06 | 170 | 119 | 6 | 03044e1436443b28dd39d5ef4fdb25c18e3a7546 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 8.45e-06 | 178 | 119 | 6 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.89e-06 | 183 | 119 | 6 | ed1e0b07475f9951728682ed70b85367cf2a744d | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-05 | 185 | 119 | 6 | 7925519b855f76444a0b57382ce35d89457b0b14 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.12e-05 | 187 | 119 | 6 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 192 | 119 | 6 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 192 | 119 | 6 | a42aed9e563f5f4af029b8804c104f11ad227a8f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 192 | 119 | 6 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-05 | 194 | 119 | 6 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-05 | 194 | 119 | 6 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 1.38e-05 | 194 | 119 | 6 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-05 | 195 | 119 | 6 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-05 | 195 | 119 | 6 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 197 | 119 | 6 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 197 | 119 | 6 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | tumor_Lung-Fibroblasts-Myofibroblasts|tumor_Lung / Location, Cell class and cell subclass | 1.55e-05 | 198 | 119 | 6 | 31f9181dab689aabe9c6182c2ef7de65ba3f0ff6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.59e-05 | 199 | 119 | 6 | 26bb93347e6722abd174dfa62cab692ce2b7eb23 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Interneuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.64e-05 | 200 | 119 | 6 | a6500d0d2e8bcac92381ab771dbdee66b0e1d48e | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-05 | 200 | 119 | 6 | 5abd6d81e1cc354484ae693fcd708d78926e75b5 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-05 | 200 | 119 | 6 | 9c9d2b0276c7b0709c2eeeb0673a2f58106fb14e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 142 | 119 | 5 | 67d4ff3483ae34f77c3325aa0fbd3462ca19ade4 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-05 | 150 | 119 | 5 | afd651c654e715414eff64cf3a37378d057a56a2 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.63e-05 | 158 | 119 | 5 | 1cefb82b9bf79c687a119be568cfc15b14c6e040 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.25e-05 | 161 | 119 | 5 | b9a17f41426bf715f30bf544a6795afaf37a3aa6 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.25e-05 | 161 | 119 | 5 | f7a89c481f789f624102857be722c95fbeb47595 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.91e-05 | 164 | 119 | 5 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.61e-05 | 167 | 119 | 5 | 02c89069dcd0e87f7502e32b14e7cbd3cab81a09 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.86e-05 | 168 | 119 | 5 | b9db0b1e4fe54a1fe79530d15d206155a1bfac39 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.11e-05 | 169 | 119 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.63e-05 | 171 | 119 | 5 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.63e-05 | 171 | 119 | 5 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | facs-Skin-nan-24m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-05 | 172 | 119 | 5 | 5ca89af7406e7e1a055dd60d6f89615f69e62324 | |
| ToppCell | metastatic_Brain-Endothelial_cells-Lymphatic_ECs|Endothelial_cells / Location, Cell class and cell subclass | 1.10e-04 | 176 | 119 | 5 | 42541dfe20eb29625d47c0bb79bf3c21a2460340 | |
| ToppCell | E12.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.13e-04 | 177 | 119 | 5 | 5cdf413f82376a95467322b16d10b0d1e7557e2d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 178 | 119 | 5 | 7467e5ab2fcb39cc4a2c7dd69722c91def3b6aea | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 179 | 119 | 5 | 4a072526c3a524a7aed99bdb32a07a1ce1f48972 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.26e-04 | 181 | 119 | 5 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.26e-04 | 181 | 119 | 5 | beb2771820956be8b190c0088ae3c4efdb53c897 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-04 | 182 | 119 | 5 | 94e70746e35a3062015d4b83ee545f4f84f47420 | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.36e-04 | 184 | 119 | 5 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_prolif-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.39e-04 | 185 | 119 | 5 | 30b7a738d91f4292d5572a50c352563e8529b8da | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.39e-04 | 185 | 119 | 5 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.46e-04 | 187 | 119 | 5 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|tumor_Lung / Location, Cell class and cell subclass | 1.50e-04 | 188 | 119 | 5 | 26326b4e298e33f9ba393fc632238aa8c54b1ea3 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 1.50e-04 | 188 | 119 | 5 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.54e-04 | 189 | 119 | 5 | 9c2492c38f27e4c699b40680652e4c64911cce52 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.54e-04 | 189 | 119 | 5 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 1.54e-04 | 189 | 119 | 5 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 190 | 119 | 5 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 190 | 119 | 5 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.62e-04 | 191 | 119 | 5 | 7b5da29109aa28768c67653a1bc0f385c2d2269b | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.62e-04 | 191 | 119 | 5 | fa9f8b50bfc7911c858bc2f9dcd204873d97ac61 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 1.62e-04 | 191 | 119 | 5 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 191 | 119 | 5 | 2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.62e-04 | 191 | 119 | 5 | b4e335e798c9617356b8e24412f9270c42dce656 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.62e-04 | 191 | 119 | 5 | c4b223b33c020a064f576711a3d700eb60a2d737 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 191 | 119 | 5 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease group,lineage and cell class (2021.01.30) | 1.62e-04 | 191 | 119 | 5 | cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12 | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 1.62e-04 | 191 | 119 | 5 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 191 | 119 | 5 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 192 | 119 | 5 | 2d9e2262f1342fe17735f21f733c029d1275e955 | |
| ToppCell | Bronchial_Brush|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.70e-04 | 193 | 119 | 5 | 3e693ac4c92576e3f2c9efdd3f1d96d3d336e260 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 1.70e-04 | 193 | 119 | 5 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 193 | 119 | 5 | 316ebdf15f75d88c348f909b643fcd315364ca84 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 193 | 119 | 5 | d0a5f212f8e8a13dbbe3e41df92548ef82eef70b | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 193 | 119 | 5 | 1afdd3f7d703f4204a2cbfe40e135ac7b09213f7 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.70e-04 | 193 | 119 | 5 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 193 | 119 | 5 | 8dc6db335678f3a5cfd36026ad811fed8d9cb4bc | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 193 | 119 | 5 | 45b5cab4dfeb0ed3b13631db5963740a792b810f | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.74e-04 | 194 | 119 | 5 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 194 | 119 | 5 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 194 | 119 | 5 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 194 | 119 | 5 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 194 | 119 | 5 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.78e-04 | 195 | 119 | 5 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.78e-04 | 195 | 119 | 5 | 43d372373367b71243c6ea958aedccde4478618f | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.78e-04 | 195 | 119 | 5 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-04 | 196 | 119 | 5 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-04 | 196 | 119 | 5 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-04 | 196 | 119 | 5 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.86e-04 | 197 | 119 | 5 | f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-04 | 197 | 119 | 5 | 09946ee8dfb15a2a32da06e5b331f3277ee934f4 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.86e-04 | 197 | 119 | 5 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | 1.86e-04 | 197 | 119 | 5 | 18fd7344628a87d5c7ef5efb66e260a4136245bf | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-04 | 197 | 119 | 5 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-04 | 197 | 119 | 5 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.91e-04 | 198 | 119 | 5 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.91e-04 | 198 | 119 | 5 | 16c54b884500066ade05a406915f9569ca8abdfc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-04 | 198 | 119 | 5 | 79576525a10ed3e3a9d1608077cd16ecda23376f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.91e-04 | 198 | 119 | 5 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial|LPS_only / Treatment groups by lineage, cell group, cell type | 1.91e-04 | 198 | 119 | 5 | e035380578c01b0243bfef29ca9b50cc17cce771 | |
| Disease | stem Cell Growth Factor beta measurement | 1.01e-05 | 75 | 112 | 5 | EFO_0008292 | |
| Disease | Nodular glomerulosclerosis | 1.79e-05 | 41 | 112 | 4 | C0017667 | |
| Disease | Diabetic Nephropathy | 2.37e-05 | 44 | 112 | 4 | C0011881 | |
| Disease | sleep apnea (is_marker_for) | 1.42e-04 | 5 | 112 | 2 | DOID:0050847 (is_marker_for) | |
| Disease | pulmonary hypertension (is_implicated_in) | 2.01e-04 | 30 | 112 | 3 | DOID:6432 (is_implicated_in) | |
| Disease | Complement deficiency disease | 2.67e-04 | 33 | 112 | 3 | C0272242 | |
| Disease | circulating alpha-Klotho measurement | 3.94e-04 | 8 | 112 | 2 | EFO_0020102 | |
| Disease | Graves' disease (is_implicated_in) | 4.40e-04 | 39 | 112 | 3 | DOID:12361 (is_implicated_in) | |
| Disease | response to angiotensin-converting enzyme inhibitor, Cough | 7.18e-04 | 46 | 112 | 3 | EFO_0005325, HP_0012735 | |
| Disease | growth rate measurement | 7.68e-04 | 11 | 112 | 2 | EFO_0010572 | |
| Disease | lower face morphology measurement | 8.05e-04 | 109 | 112 | 4 | EFO_0010948 | |
| Disease | Hypertensive disease | 8.07e-04 | 190 | 112 | 5 | C0020538 | |
| Disease | pulmonary hypertension (implicated_via_orthology) | 1.15e-03 | 54 | 112 | 3 | DOID:6432 (implicated_via_orthology) | |
| Disease | hypertension (is_implicated_in) | 1.19e-03 | 121 | 112 | 4 | DOID:10763 (is_implicated_in) | |
| Disease | chronic obstructive pulmonary disease (is_implicated_in) | 1.79e-03 | 63 | 112 | 3 | DOID:3083 (is_implicated_in) | |
| Disease | renal fibrosis (implicated_via_orthology) | 1.87e-03 | 17 | 112 | 2 | DOID:0050855 (implicated_via_orthology) | |
| Disease | Antibody Deficiency Syndrome | 1.87e-03 | 17 | 112 | 2 | C0003257 | |
| Disease | glaucoma (is_marker_for) | 2.59e-03 | 20 | 112 | 2 | DOID:1686 (is_marker_for) | |
| Disease | PR interval | 2.86e-03 | 495 | 112 | 7 | EFO_0004462 | |
| Disease | Kidney Failure | 3.14e-03 | 22 | 112 | 2 | C0035078 | |
| Disease | Immunologic Deficiency Syndromes | 3.43e-03 | 23 | 112 | 2 | C0021051 | |
| Disease | Behcet Syndrome | 3.73e-03 | 24 | 112 | 2 | C0004943 | |
| Disease | Ureteral obstruction | 3.73e-03 | 24 | 112 | 2 | C0041956 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HFEPNEYIHYDLLEK | 36 | Q99798 | |
| IKYLRVFHPYHFELV | 331 | Q8N5R6 | |
| YVSHFETEGPHVLLY | 1511 | P0C0L5 | |
| HHPEYLVGEEALYVN | 161 | Q9H981 | |
| HLYFYARVHGIPEKD | 2351 | Q86UK0 | |
| ADYYGHLKEPLLTFH | 276 | Q8WUY9 | |
| IYEAHIHLNGYPFLD | 571 | P51793 | |
| HHYGVEKADIPAKYA | 181 | Q8TEK3 | |
| VAPHYYKAKELEDPH | 1011 | O60231 | |
| HRHYLHPEEPEYLGK | 396 | Q5T5Y3 | |
| YFKHDPEHKFIYRFV | 181 | Q8N7R7 | |
| EGGYHPHIVYRRQKV | 186 | P58397 | |
| EKLDYHHYLPLFFDG | 101 | Q96M98 | |
| FVPFHSDLGYRHKYI | 361 | Q8N2K0 | |
| VYYRLGEHNKHLDGI | 306 | O43827 | |
| YHLKGIHRAVFYRDL | 31 | Q5JPF3 | |
| YSILEIHHGRLQYKF | 3876 | Q14517 | |
| LHPHRIDIFEDYIYG | 4116 | Q9NZR2 | |
| RYLTPGDIYVHADLH | 556 | O60524 | |
| ICGHYPRHIVFLEYE | 81 | Q8NCE2 | |
| DFFYQGVHRHEEYLP | 176 | Q86W28 | |
| SGYLRYSFHHEEKVP | 41 | Q8TBE3 | |
| FAALAHYKLVYIHPF | 351 | Q9BVA6 | |
| HYKLVYIHPFIDGNG | 356 | Q9BVA6 | |
| RVLDELKHYYHGFRL | 156 | O95202 | |
| YIAGAPRYKHHGAVF | 476 | P38570 | |
| APFYHVHGEEGRVYV | 536 | P38570 | |
| LIYHKEIPFYNHLDF | 361 | P07098 | |
| EEYHLYKDGHLPISE | 1761 | Q92817 | |
| GLPVYLYEFEHHARG | 441 | Q5XG92 | |
| ELFPYVLHFYHTGKL | 76 | Q9ULS6 | |
| KYLLHFSHYVNEVVP | 141 | Q9Y2G8 | |
| YIHDHFIPIEKYQFS | 796 | P48357 | |
| KHIVERYTEFYHVPT | 241 | Q96HC4 | |
| AYATYPRELKHIFHV | 721 | Q9H8H2 | |
| EYLHNYGIVHRDLKP | 486 | Q9Y2H9 | |
| YEADHILPHGFCYII | 151 | Q13797 | |
| YFYHRETDHEEPAVL | 521 | P22460 | |
| YLHEEAARYPKKIHY | 1236 | Q9Y6J0 | |
| YLLYGFHLEPLFKCH | 176 | P57773 | |
| DFGLARDIHHIDYYK | 641 | P11362 | |
| GIHYITLDGRVYDLH | 4861 | Q9Y6R7 | |
| QIGHIPREDVDYHLY | 2176 | P02751 | |
| KHGHARALYVLVVYD | 296 | Q8NFZ8 | |
| VRKIAPEYYDHLPQH | 276 | Q6QHC5 | |
| EEIKPLYEHLHAYVR | 231 | Q9BYF1 | |
| GYAQLRHHLPEEYLE | 111 | Q9NQ33 | |
| RYPVHFHLCGDVDYK | 546 | Q9UHN6 | |
| PKIHHGFLYDEEDYN | 26 | Q9BXR6 | |
| HAVYGKLLLFEYRHR | 201 | Q9NS66 | |
| SHYRKVHEGDSEPRY | 331 | Q9BQA5 | |
| SFEDALHRLLPYHVY | 1106 | Q9NZM4 | |
| EHHEIFSYPEIYFLG | 171 | Q92630 | |
| YGLLDPSVFHVKYRA | 331 | Q9BVI4 | |
| YVSHFETEGPHVLLY | 1511 | P0C0L4 | |
| AHYYRDYVVKKGLGH | 176 | Q9UJX0 | |
| HKRYFVLEDGILHYA | 66 | Q9BZF2 | |
| GHYYDILELPYHGDT | 241 | P05121 | |
| YFEINYVRKEHHLVP | 101 | Q4G0U5 | |
| HQYHIRAYDPKGGLD | 281 | P15104 | |
| HAIKELGYLEYDHPE | 786 | Q4G0N8 | |
| VFGPYYAEILKHIIH | 381 | Q5H9J9 | |
| RTAYAHYHVEKLFGL | 321 | Q8IW70 | |
| DLHDVPKGYSFYLAH | 201 | Q7L592 | |
| FYDRAEYLHGKHGVD | 111 | Q9HCE1 | |
| YDELHKVHYLFGGNP | 591 | Q9UL63 | |
| EAHFELVHYAGVVPY | 586 | Q9Y2K3 | |
| AEGKLHFPESLHLYY | 321 | Q7RTZ1 | |
| RPYTIHPHGVFYEKD | 121 | Q9BQS7 | |
| GHYGYIDLELPCFHV | 81 | O14802 | |
| VYLEHRSPDGAIHYL | 766 | Q8TF17 | |
| RHHAVEYYRAGAVPL | 1101 | Q8TF17 | |
| LYGQHFPIEVRHYLS | 21 | P51692 | |
| YEAELAVHLPQGAHY | 676 | P08514 | |
| FEGEYTHHKDPGIYK | 71 | Q8IXL7 | |
| LAAGQHDLVPHYYVE | 271 | Q96GD0 | |
| LYGQHFPIEVRHYLA | 21 | P42229 | |
| YHPVKIGDVFNGRYH | 66 | Q9UPE1 | |
| ALYKYEALHLHYPIE | 61 | Q8TDG2 | |
| RDKFEHPNSYYHPVF | 291 | Q7L1S5 | |
| PGDDYDHGTAHKYII | 776 | A8K7I4 | |
| GHKEFYPVKEFEVYH | 56 | Q86W10 | |
| YLVYHRRLHTGEKPY | 341 | Q96IR2 | |
| VSHVIDPCHFYIRKY | 421 | Q9BXT8 | |
| HIRSHLGHKPYDYQE | 121 | Q8TBZ8 | |
| YLVQHGRLHTGEKPY | 386 | P17039 | |
| GPIRDVLHHIYSALY | 91 | Q9Y5R8 | |
| YLDNIHLHPEEEKYR | 181 | Q9BZV1 | |
| LYLIHERTHTGEKPY | 236 | Q9H0M5 | |
| LRYHERTHTGEKPYE | 551 | Q9H0M5 | |
| YLIDHQRLHKGEEPY | 496 | O14709 | |
| YLFDHQRLHNGEKPY | 636 | O14709 | |
| YFICHHRLHTGEKPY | 676 | Q86XN6 | |
| IRYHERTHTGEKPYE | 466 | P17024 | |
| AVHEVYAPHFDPRYG | 226 | Q8N8G2 | |
| HHPVYILKGGYERFS | 121 | Q9Y6J8 | |
| RIYIKHPHLFKYAAD | 231 | Q9H147 | |
| VYPGDPLRFHAHYIA | 246 | Q9BSV6 | |
| HFPEGEHVIRYTAYD | 231 | O60687 | |
| VHYHYGPKDLVTILF | 66 | Q15035 | |
| AGASPHRVHYDLKYA | 686 | Q9P253 | |
| YIRVGAGHKPYEYHE | 121 | Q96GE5 | |
| HRRYYHTGEKPFDCI | 386 | Q6ECI4 | |
| DVLHLGEEAPSHLYY | 546 | Q6ZN44 | |
| LVRYHERIHTGEKPY | 351 | Q8TA94 | |
| YLHFAYHKVVEGILD | 291 | Q9GZM5 | |
| VYHAHYKPLEFTVAG | 426 | Q9NNW7 | |
| FIRHYIIHTGEKPYE | 326 | Q08ER8 | |
| KTYHYLVDPHFAQVF | 3991 | Q7Z7G8 | |
| YIRVGAGHKPHEYHE | 121 | Q9Y2A4 | |
| LSEHYRIHTGEKPYE | 506 | Q8TBZ5 | |
| REKGPLVFHHHYLPY | 101 | P0C7W0 | |
| FLVHYGHRCLIYPFL | 91 | P18405 | |
| HLRDYPEKYFFLIHC | 161 | Q9NRZ5 | |
| YLIEHQRIHTGEKPY | 396 | Q6ZN57 | |
| FRYHGRTHTGEKPYE | 521 | Q8N7K0 | |
| PRLHGHFEQYKVDYT | 811 | Q9UPU7 | |
| YEDALYTVLHRLGHP | 56 | Q70J99 | |
| YLREHERTHTGEKPY | 211 | Q9BS34 | |
| YFRIHERSHTGEKPY | 461 | P17017 | |
| ELVEYYKHHSLKEGF | 741 | Q9UKW4 | |
| DLILPHYHTFYDFII | 241 | Q9Y247 | |
| LIPHYNHVDFYLGED | 366 | Q5VXJ0 | |
| LEPHIYAVADVAYHA | 211 | B2RTY4 |